Vang Russell, Herrmann Marille E, Tavassoli Fattaneh A
Armed Forces Institute of Pathology, Department of Gynecologic & Breast Pathology, Washington DC, USA.
Int J Gynecol Pathol. 2004 Apr;23(2):151-61. doi: 10.1097/00004347-200404000-00010.
Granulosa cell tumors of the ovary occasionally show admixed Sertoli components, just as tumors that are predominantly Sertoli or Sertoli-Leydig cell tumors can contain minor granulosa elements. Although the immunoprofiles of pure granulosa cell tumors and pure Sertoli cell tumors have been characterized, little is known regarding what immunophenotypic relationships exist between the granulosa and Sertoli components in ovarian sex cord-stromal tumors that contain both elements. Furthermore, it is not completely understood why sex cord-stromal tumors of the ovary with female-type (granulosa) differentiation can produce male-type (Sertoli) differentiation. To better understand why simultaneous differentiation into female-type and male-type components occurs, eight tumors with mixed differentiation were stained with a panel of antibodies to androgen receptor (AR), calretinin, CD10, CD99, estrogen receptor, inhibin, Ki-67, low molecular weight cytokeratin, pancytokeratin, progesterone receptor, p53, and vimentin. Immunohistochemical composite scores were determined separately for the matched pairs of granulosa and Sertoli components in each case. Differences between both components were statistically analyzed using the Wilcoxon signed rank test. AR and vimentin expression showed a difference at the 10% statistical significance level (p < 0.1), demonstrating higher levels of expression in the granulosa components. The differences between the granulosa and Sertoli components in expression of CD99, inhibin, or pancytokeratin were not statistically significant (p > 0.1, each). Statistical calculations could not be made for calretinin, CD10, estrogen receptor, Ki-67, low molecular weight cytokeratin, progesterone receptor, or p53, although the overall mean levels of expression of CD10 and low molecular weight cytokeratin were substantially higher in the Sertoli components. Not surprisingly, the granulosa and Sertoli components of ovarian sex cord-stromal tumors with mixed differentiation show overlapping immunophenotypic profiles consistent with derivation from a common lineage rather than reflecting a composite tumor. However, because components of a sex cord-stromal tumor simultaneously differentiate along granulosa or Sertoli lines, they seem to show preferential expression of certain antigens. CD10 and low molecular weight cytokeratin are more often associated with Sertoli cell differentiation, whereas AR and vimentin expression seem to reflect granulosa differentiation.
卵巢颗粒细胞瘤偶尔会显示混合有支持细胞成分,正如以支持细胞或支持-间质细胞瘤为主的肿瘤可含有少量颗粒细胞成分一样。尽管纯颗粒细胞瘤和纯支持细胞瘤的免疫表型已得到描述,但对于同时含有颗粒细胞和支持细胞成分的卵巢性索间质肿瘤中,这两种成分之间存在何种免疫表型关系却知之甚少。此外,卵巢具有女性型(颗粒细胞)分化的性索间质肿瘤为何会产生男性型(支持细胞)分化也尚未完全明了。为了更好地理解为何会同时分化为女性型和男性型成分,对8例具有混合分化的肿瘤用一组针对雄激素受体(AR)、钙视网膜蛋白、CD10、CD99、雌激素受体、抑制素、Ki-67、低分子量细胞角蛋白、全细胞角蛋白、孕激素受体、p53和波形蛋白的抗体进行染色。分别测定每例中颗粒细胞和支持细胞成分匹配对的免疫组织化学综合评分。使用Wilcoxon符号秩和检验对两种成分之间的差异进行统计学分析。AR和波形蛋白的表达在10%的统计学显著性水平上显示出差异(p < 0.1),表明在颗粒细胞成分中表达水平更高。颗粒细胞和支持细胞成分在CD99、抑制素或全细胞角蛋白表达上的差异无统计学意义(p均> 0.1)。对于钙视网膜蛋白、CD10、雌激素受体、Ki-67、低分子量细胞角蛋白、孕激素受体或p53无法进行统计计算,尽管CD10和低分子量细胞角蛋白的总体平均表达水平在支持细胞成分中显著更高。不出所料,具有混合分化的卵巢性索间质肿瘤的颗粒细胞和支持细胞成分显示出重叠的免疫表型特征,这与源自共同谱系一致,而非反映复合肿瘤。然而,由于性索间质肿瘤的成分同时沿颗粒细胞或支持细胞系分化,它们似乎显示出某些抗原的优先表达。CD10和低分子量细胞角蛋白更常与支持细胞分化相关,而AR和波形蛋白的表达似乎反映颗粒细胞分化。